/People

Michael Krel

Investor

Partner, Industrial Biotech Strategy at Sofinnova Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

Find your path to Michael

Sign up to see every warm intro you have to Michael

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Michael. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Partner in Sofinnova's Industrial Biotech Strategy since 2013, focused on early-stage deals in Europe and North America across chemicals, materials, agriculture, food, feed, and synthetic biology. Previously spent six years in industrial biotech startups in business development and worked in strategy consulting; also served two years as CEO of portfolio company EnobraQ.

Contact· self-published, not guessed

Invests in

AgTechBiotechClimate TechFoodTechNew Materials

Investments

Board seats

AfyrenComet BioElicit PlantEnginzymeEnobraQMeiogenix

Per the firm's website.

Colleagues at Sofinnova Partners

Network3

Investors connected to Michael in public investor directories — a warm-intro map.

Frequently asked questions

Who is Michael Krel?
Partner in Sofinnova's Industrial Biotech Strategy since 2013, focused on early-stage deals in Europe and North America across chemicals, materials, agriculture, food, feed, and synthetic biology. Previously spent six years in industrial biotech startups in business development and worked in strategy consulting; also served two years as CEO of portfolio company EnobraQ.
Where does Michael Krel work?
Michael Krel is Partner, Industrial Biotech Strategy at Sofinnova Partners.
What does Michael Krel invest in?
Michael Krel invests in AgTech, Biotech, Climate Tech, FoodTech, New Materials.
What check size does Michael Krel write?
Michael Krel typically writes checks of $100K – $5M.
What boards does Michael Krel sit on?
Michael Krel holds tracked board seats at Afyren, Comet Bio, Elicit Plant, Enginzyme, EnobraQ, Meiogenix.

About this profile. Compiled from public sources — Sofinnova Partners's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights